1. Home
  2. AYTU vs TRUG Comparison

AYTU vs TRUG Comparison

Compare AYTU & TRUG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AYTU
  • TRUG
  • Stock Information
  • Founded
  • AYTU N/A
  • TRUG 1983
  • Country
  • AYTU United States
  • TRUG United States
  • Employees
  • AYTU N/A
  • TRUG N/A
  • Industry
  • AYTU Biotechnology: Pharmaceutical Preparations
  • TRUG
  • Sector
  • AYTU Health Care
  • TRUG
  • Exchange
  • AYTU Nasdaq
  • TRUG NYSE
  • Market Cap
  • AYTU 9.6M
  • TRUG 7.0M
  • IPO Year
  • AYTU N/A
  • TRUG N/A
  • Fundamental
  • Price
  • AYTU $2.21
  • TRUG $6.15
  • Analyst Decision
  • AYTU Strong Buy
  • TRUG Strong Buy
  • Analyst Count
  • AYTU 2
  • TRUG 1
  • Target Price
  • AYTU $10.00
  • TRUG $100.00
  • AVG Volume (30 Days)
  • AYTU 663.3K
  • TRUG 106.7K
  • Earning Date
  • AYTU 05-14-2025
  • TRUG 08-13-2025
  • Dividend Yield
  • AYTU N/A
  • TRUG N/A
  • EPS Growth
  • AYTU N/A
  • TRUG N/A
  • EPS
  • AYTU N/A
  • TRUG N/A
  • Revenue
  • AYTU $81,659,000.00
  • TRUG $22,236,072.00
  • Revenue This Year
  • AYTU N/A
  • TRUG $15.89
  • Revenue Next Year
  • AYTU $8.68
  • TRUG $40.93
  • P/E Ratio
  • AYTU N/A
  • TRUG N/A
  • Revenue Growth
  • AYTU 0.41
  • TRUG 8.40
  • 52 Week Low
  • AYTU $0.95
  • TRUG $5.15
  • 52 Week High
  • AYTU $2.96
  • TRUG $73.50
  • Technical
  • Relative Strength Index (RSI)
  • AYTU 63.18
  • TRUG 31.38
  • Support Level
  • AYTU $2.04
  • TRUG $5.15
  • Resistance Level
  • AYTU $2.40
  • TRUG $6.71
  • Average True Range (ATR)
  • AYTU 0.14
  • TRUG 0.95
  • MACD
  • AYTU 0.00
  • TRUG -0.17
  • Stochastic Oscillator
  • AYTU 54.90
  • TRUG 14.08

About AYTU Aytu BioPharma Inc.

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which the company generates maximum revenue from the Rx segment.

About TRUG TRUGOLF HOLDINGS INC

TruGolf Holdings Inc is a indoor golf gaming solutions company. It has built video games (including Links, a sports game for PC), hardware solutions, and an all-new e-sports platform to connect golfers around the world with E6 CONNECT.

Share on Social Networks: